glp-1 and kidneys Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus chronic kidney disease: an approach for the nephrologist Potential kidney-protective and other effects

GLP-1 related hair loss is predominantly telogen effluvium, which is a temporary and self-resolving condition

Can J Physiol Pharmacol

The FDAs new guidance clarifies that, unless theres a legitimate shortage, copying an FDA-approved drug is not permissible

Now, if you want to take your health optimization journey to the next level Youll have to dive deeper into using peptides to optimize health, especially if youre in your 30s and beyond

The new BSG & ACPGBI guidance makes it clear: A negative FIT does not rule out GI cancer in IDA Upper GI malignancy risk remains significant Bidirectional endoscopy is still key FIT must not delay investigation in high-risk patients Full guidance in Frontline Gastroenterology: #IDA #FIT #CancerPathways #GIguidelines #FGJournal @British society of gastroenterology @Royal College of Physicians @Oliver Tavabie @benjamin zare @European Society of Gastrointestinal Endoscopy @EASL - The Home of Hepatology @American College of Gastroenterology @American Association for the Study of Liver Diseases (AASLD) @TrevorTabone To view or add a comment, sign in 6,825 followers

Here are some common concerns related to stopping GLP-1 treatment